choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Amarin Patent

Amarin Patent Newsletter
  • Amarin Corporation plc (NASDAQ:AMRN) Q3 2025 Earnings Call Transcript 30 Oct 2025 12:40 GMT

    … where VASCEPA benefits from extended patent protection until 2039, and there … ;A Session Follow Amarin Corp Plc (NASDAQ:AMRN) Follow Amarin Corp Plc (NASDAQ:AMRN … your participation. Follow Amarin Corp Plc (NASDAQ:AMRN) Follow Amarin Corp Plc (NASDAQ:AMRN …

  • Amarin Corporation plc (NASDAQ:AMRN) Q1 2025 Earnings Call Transcript 09 May 2025 12:20 GMT

    … base across European markets with patent protection through 2039. While encouraging … and Europe, especially Europe, with patent protection to 2039, we’ve … your participation. Follow Amarin Corp Plc (NASDAQ:AMRN) Follow Amarin Corp Plc (NASDAQ:AMRN …

  • Amarin Corporation plc (NASDAQ:AMRN) Q4 2024 Earnings Call Transcript 13 Mar 2025 12:40 GMT

    … March 12, 2025 Amarin Corporation plc beats earnings expectations … Europe where we have patent protection out to … Session Follow Amarin Corp Plc (NASDAQ:AMRN) Follow Amarin Corp Plc … participation. Follow Amarin Corp Plc (NASDAQ:AMRN) Follow Amarin Corp Plc ( …

  • Amarin Corp files patent for pharmaceutical composition for treating carious diseases and disorders 06 Mar 2024 15:58 GMT

    … key innovation area identified from patents. Amarin Corp's grant share as … United States Patent and Trademark Office (USPTO). Credit: Amarin Corp Plc A … recently filed patent (Publication Number: US20240024269A1 …

  • Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript 03 May 2024 14:22 GMT

    … built upon a multilayered collection patent and regulatory protection such … to these patents, Amarin possesses additional European patents and pending patent applications that … A Session Follow Amarin Corp Plc (NASDAQ:AMRN) Follow Amarin Corp Plc (NASDAQ:AMRN …

  • Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript 01 Mar 2024 13:54 GMT

    … February 29, 2024 Amarin Corporation plc beats earnings expectations … Europe. We have patents and applications that have … successfully defended our 2033 patent from opposition. We expect … Session Follow Amarin Corp Plc (NASDAQ:AMRN) Follow Amarin Corp Plc ( …

  • Amarin Corporation plc (NASDAQ:AMRN) Q3 2023 Earnings Call Transcript 02 Nov 2023 15:10 GMT

    … November 1, 2023 Amarin Corporation plc misses on earnings … . Operator: Welcome to Amarin Corporation’s conference call to … and we also have patents and applications that have … Session Follow Amarin Corp Plc (NASDAQ:AMRN) Follow Amarin Corp Plc (NASDAQ …

  • Amarin Corp.: Hitting The Thesis Reset Button 21 Apr 2022 05:41 GMT

    … the unfavorable ruling in their patent lawsuit against generics Dr. … Du found Vascepa’s patents to be obvious, so … s action to resuscitate their patents. Accordingly, Amarin reduced … the globe. Amarin Partnerships (Amarin Corp) Considering the points above, …

  • Amarin Corporation plc (AMRN) CEO Karim Mikhail on Q4 2021 Results - Earnings Call Transcript 01 Mar 2022 15:36 GMT

    Amarin Corporation plc (NASDAQ:AMRN) Q4 … SVB Leerink Operator Welcome to Amarin Corporation Conference Call to discuss its … decision. Amarin believes that its patents are being infringed upon and … vigorously continue to defend our patents on all fronts. Thank …

  • Is Amarin Corp. (AMRN) A Smart Long-Term Buy? 27 Dec 2021 12:02 GMT

    … Q3 2021 investor letter, mentioned Amarin Corporation plc (NASDAQ: AMRN) and discussed … .S. business, where a tragic patent ruling undermined Amarin’s intellectual … enjoys.” Based on our calculations, Amarin Corporation plc (NASDAQ: AMRN) was not …

Satisfied with the content?

Continue to create your account.